Credit rating
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that Credit Analysis & Research Ltd (CARE) has reaffirmed the following credit rating for long term and short term bank facilities of the Company:Long term Bank Facilities : 'CARE BB-' (Double B Minus)Short term Bank Facilities : 'CARE A4' (A Four) Outcome of Board Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 30, 2016, has considered and approved the following matters:1. Re-appointment of Mr. Vijay Kumar Garg as Joint Managing Director of the Company for three year w.e.f. March 02, 2016.2. Re-appointment of Mr. Vijay Singla as Director (works) of the Company for three year w.e.f. April 01, 2016.... Financial Results & Limited Review Report for Dec 31, 2015 (Standalone)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report (Standalone) for the period ended December 31, 2015. Board Intimation for Results & Closure of Trading Window
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled to be held on January 30, 2016, inter alia, to consider and approve the un-audited financial results of the Company for the quarter ended December 31, 2015.Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window of the Company shall remain closed from... Shareholding for the Period Ended December 31, 2015
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Change in address of Registrar and Share Transfer Agent (RTA)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding "Change in address of Registrar and Share Transfer Agent (RTA)". Outcome of Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in its meeting held on November 30, 2015 has allotted 4,00,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. On the allotment... Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Innova Marchantiles Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Outcome of Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in its meeting held on November 27, 2015 has allotted 7,25,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval....